Don't get caught up in the hype over new Alzheimer's drug

We must distinguish between improvement that is statistically significant but not necessarily clinically meaningful. And weigh it against costs and side effects.

Related Keywords

Germany ,Japan ,United States ,United Kingdom ,Japanese ,Americans ,American ,German ,Auguste Deter ,Alois Alzheimer ,Centers For Medicaid Medicare Services ,Drug Administration ,Star Tribune Opinion ,New England Journal ,Clinical Dementia Rating ,Big Pharma ,